regenacy.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | Regenacy |
| Description | RESTORING NERVE Regenacy Pharmaceuticals is a pioneer in developing novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme ("HDAC") |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.49.23.145 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
regenacy.com Valuation
|
US$970,456
Last updated: 2022-06-18 00:02:39
regenacy.com has Semrush global rank of 10,906,532. regenacy.com has an estimated worth of US$ 970,456, based on its estimated Ads revenue. regenacy.com receives approximately 111,976 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.145. According to SiteAdvisor, regenacy.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$970,456 |
| Daily Ads Revenue | US$896 |
| Monthly Ads Revenue | US$26,875 |
| Yearly Ads Revenue | US$322,490 |
| Daily Unique Visitors | 7,466 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| regenacy.com. | A | 600 | IP: 198.49.23.145 |
| regenacy.com. | A | 600 | IP: 198.185.159.144 |
| regenacy.com. | A | 600 | IP: 198.185.159.145 |
| regenacy.com. | A | 600 | IP: 198.49.23.144 |
| regenacy.com. | NS | 3600 | NS Record: ns58.domaincontrol.com. |
| regenacy.com. | NS | 3600 | NS Record: ns57.domaincontrol.com. |
| regenacy.com. | MX | 3600 | MX Record: 0 regenacy-com.mail.protection.outlook.com. |
| regenacy.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-18 00:02:39
| our STORY our FOCUS our PIPELINE our TEAM NEWS & PUBLICATIONS our STORY our FOCUS our PIPELINE our TEAM NEWS & PUBLICATIONS Scroll RESTORING NERVE FUNCTION to treat diabetic and other peripheral neuropathies LATEST NEWS 12.21.20 - PRESS RELEASE: REGENACY ANNOUNCES THE FORMATION OF A JOINT VENTURE WITH 3E BIOVENTURES TO DEVELOP RICOLINOSTAT IN CHINA AND THE START OF A U.S. PHASE 2 STUDY IN PAINFUL DIABETIC PERIPHERAL NEUROPATHY READ MORE OUR FOCUS OUR PIPELINE OUR TEAM OUR STORY Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function. Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, that will be entering a proof-of-concept (PoC) Phase 2 clinical trial in diabetic peripheral neuropathy. Our investigation of ricolinostat for diabetic, chemotherapy-induced, |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 0 Date: Fri, 22 Oct 2021 09:19:34 GMT Location: https://regenacy.com/ Server: Squarespace Set-Cookie: crumb=BRREICfOgZIcZWViOTBkNDc1MTA0YzNhNGM1ZTc5NzE2ZGMyMmNh;Path=/ X-Contextid: En8V3LUI/o742rnXk HTTP/2 200 accept-ranges: bytes age: 14307 content-type: text/html;charset=utf-8 date: Fri, 22 Oct 2021 05:21:07 GMT etag: W/"81a3494ac1e1358e3cbbfd72573118f1--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BXhgVy85A6zrNTg3NzBkMGZiYzQwYjRhYWIwNWY1YmIzODljZTY0;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: qmPdWd4K/O9Rl2iRT |
regenacy.com Whois Information
Domain Name: REGENACY.COM Registry Domain ID: 2069663892_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-10-14T13:31:45Z Creation Date: 2016-10-28T12:19:48Z Registry Expiry Date: 2022-10-28T12:19:48Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS57.DOMAINCONTROL.COM Name Server: NS58.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T00:56:35Z <<< |